|

The Prevalence, Risk Factors and Optimal Biopsy Protocol of BE

RECRUITINGN/ASponsored by E-DA Hospital
Actively Recruiting
PhaseN/A
SponsorE-DA Hospital
Started2023-03-13
Est. completion2025-12-31
Eligibility
Age20 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT05818072

Summary

Detections of goblet cells and dysplasia are crucial for diagnosis and determining the surveillance program of Barrett's esophagus (BE). However, the optimal biopsy numbers and their yield rates of intestinal metaplasia (IM) and dysplasia are still uncertain, especially in Asia. The aim of this study was to determine the optimal biopsy protocol of BE.

Eligibility

Age: 20 Years+Healthy volunteers accepted
Inclusion Criteria:

* Adults with columnar-lined esophagus

Exclusion Criteria:

* A prior history of endoscopic treatment for Barrett's Esophagus
* A prior history of upper gastrointestinal malignancy
* A prior history of total or subtotal gastrectomy
* Esophageal varices noted during the procedure
* Uncontrolled coagulopathy
* Taking antiplatelet drug or anticoagulant

Conditions3

Barrett's EsophagusCancerIntestinal Metaplasia

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.